Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Study of Endothelial Cell Condition After Cataract Surgery Performed Using Capsulorhexis or ZEPTO
- Conditions
- Endothelial Cell Density Loss
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Centricity Vision, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04882189
- Locations
- 🇺🇸
UltraVision, San Antonio, Texas, United States
🇺🇸Houston Eye Associates, Houston, Texas, United States
News
No news found